U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Cutaneous abscess

MedGen UID:
450991
Concept ID:
C0149777
Pathologic Function
Synonym: Skin abscesses
SNOMED CT: Skin abscess (31928004); Cutaneous abscess (31928004); Abscess of skin and/or subcutaneous tissue (31928004)
 
HPO: HP:0031292

Definition

A circumscribed area of pus or necrotic debris in the skin. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVCutaneous abscess

Conditions with this feature

Immunodeficiency 51
MedGen UID:
934770
Concept ID:
C4310803
Disease or Syndrome
Immunodeficiency-51 (IMD51) is an autosomal recessive primary immune deficiency that is usually characterized by onset of chronic mucocutaneous candidiasis in the first years of life. Most patients also show recurrent Staphylococcal skin infections, and may show increased susceptibility to chronic bacterial respiratory infections. Patient cells show a lack of cellular responses to stimulation with certain IL17 isoforms, including IL17A (603149), IL17F (606496), IL17A/F, and IL17E (IL25; 605658) (summary by Levy et al., 2016).
Hyper-IgE recurrent infection syndrome 1, autosomal dominant
MedGen UID:
1648470
Concept ID:
C4721531
Disease or Syndrome
STAT3 hyper IgE syndrome (STAT3-HIES) is a primary immune deficiency syndrome characterized by elevated serum IgE, eczema, and recurrent skin and respiratory tract infections, together with several nonimmune features. This disorder typically manifests in the newborn period with a rash (often diagnosed as eosinophilic pustulosis) that subsequently evolves into an eczematoid dermatitis. Recurrent staphylococcal skin boils and bacterial pneumonias usually manifest in the first years of life. Pneumatoceles and bronchiectasis often result from aberrant healing of pneumonias. Mucocutaneous candidiasis is common. Nonimmune features may include retained primary teeth, scoliosis, bone fractures following minimal trauma, joint hyperextensibility, and characteristic facial appearance, which typically emerges in adolescence. Vascular abnormalities have been described and include middle-sized artery tortuosity and aneurysms, with infrequent clinical sequelae of myocardial infarction and subarachnoid hemorrhage. Gastrointestinal (GI) manifestations include gastroesophageal reflux disease, esophageal dysmotility, and spontaneous intestinal perforations (some of which are associated with diverticuli). Fungal infections of the GI tract (typically histoplasmosis, Cryptococcus, and Coccidioides) also occur infrequently. Survival is typically into adulthood, with most individuals now living into or past the sixth decade. Most deaths are associated with gram-negative (Pseudomonas) or filamentous fungal pneumonias resulting in hemoptysis. Lymphomas occur at an increased frequency.
Combined immunodeficiency due to DOCK8 deficiency
MedGen UID:
1648410
Concept ID:
C4722305
Disease or Syndrome
Hyper-IgE syndrome-2 with recurrent infections (HIES2) is an autosomal recessive immunologic disorder characterized by recurrent staphylococcal infections of the skin and respiratory tract, eczema, elevated serum immunoglobulin E, and hypereosinophilia. It is distinguished from autosomal dominant HIES1 (147060) by the lack of connective tissue and skeletal involvement (Renner et al., 2004). For a discussion of genetic heterogeneity of hyper-IgE syndrome, see 147060. See also TYK2 deficiency (611521), a clinically distinct disease entity that includes characteristic features of both autosomal recessive HIES2 and mendelian susceptibility to mycobacterial disease (MSMD; 209950) (Minegishi et al., 2006).
Severe combined immunodeficiency due to CARMIL2 deficiency
MedGen UID:
1648422
Concept ID:
C4748304
Disease or Syndrome
Immunodeficiency-58 is an autosomal recessive primary immunologic disorder characterized by early-onset skin lesions, including eczematous dermatitis, infectious abscesses, and warts, recurrent respiratory infections or allergies, and chronic persistent infections with candida, Molluscum contagiosum, mycobacteria, EBV, bacteria, and viruses. Some patients may have gastrointestinal involvement, including inflammatory bowel disease, EBV+ smooth muscle tumors, and esophagitis. Immunologic analysis shows defective T-cell function with decreased Treg cells and deficient CD3/CD28 costimulation responses in both CD4+ and CD8+ T cells. B-cell function may also be impaired (summary by Wang et al., 2016 and Alazami et al., 2018).
Immunodeficiency 15a
MedGen UID:
1648385
Concept ID:
C4748694
Disease or Syndrome
Immunodeficiency 15A (IMD15A) is an autosomal dominant primary immunodeficiency disorder characterized by relatively late onset of recurrent respiratory tract infections and lymphopenia, combined with immune activation of both CD4+ and CD8+ T cells. One patient presented with inflammatory disease and possible ectodermal defect.
Hyper-IgE recurrent infection syndrome 3, autosomal recessive
MedGen UID:
1648483
Concept ID:
C4748969
Disease or Syndrome
Hyper-IgE syndrome-3 with recurrent infections (HIES3) is an autosomal recessive immunologic disorder characterized by childhood onset of atopic dermatitis, skin infections particularly with Staphylococcus aureus, recurrent sinopulmonary infections, and increased serum IgE and IgG. Patients are susceptible to bacterial and fungal infections, including chronic mucocutaneous candidiasis. Immunologic workup shows impaired differentiation of CD4+ T cells into T-helper 17 cells, decreased memory B cells, and often decreased NK cells (summary by Beziat et al., 2018). For a discussion of genetic heterogeneity of hyper-IgE syndrome, see HIES1 (147060).
Hyper-IgE recurrent infection syndrome 5, autosomal recessive
MedGen UID:
1716052
Concept ID:
C5394550
Disease or Syndrome
Hyper-IgE syndrome-5 with recurrent infections (HEIS5) is an autosomal recessive immunologic disorder characterized by onset of recurrent sinopulmonary and deep skin infections in early childhood. The infections are mostly caused by bacteria, including H. influenza and Staphylococcus aureus. Additional features include atopic dermatitis, impaired inflammatory responses during infection, increased serum IgE, and increased IL6 (147620) (summary by Spencer et al., 2019). For a discussion of genetic heterogeneity of hyper-IgE syndrome, see HIES1 (147060).
Immunodeficiency 77
MedGen UID:
1788976
Concept ID:
C5543173
Disease or Syndrome
Immunodeficiency-77 (IMD77) is an immunologic disorder characterized by recurrent and persistent polymicrobial infections with multiple unusual organisms. Skin and pulmonary infections are the most common, consistent with increased susceptibility to epithelial cell infections. The age at onset is highly variable: some patients have recurrent infections from childhood, whereas others present in late adulthood. The limited number of reported patients are all female, suggesting incomplete penetrance or a possible sex-influenced trait. Patient cells, mainly macrophages, show impaired killing of intracellular bacteria and organisms, including nontubercular mycobacteria, although there is also impaired killing of other organisms, such as Pseudomonas, Candida, and Aspergillus. Treatment with gamma-IFN (IFNG; 147570) may be a therapeutic option (summary by McCormack et al., 2017 and Merselis et al., 2020).
Hyper-IgE recurrent infection syndrome 4A, autosomal dominant
MedGen UID:
1809613
Concept ID:
C5676920
Disease or Syndrome
Hyper-IgE syndrome-4A with recurrent infections (HIES4A) is an autosomal dominant immunologic disorder characterized by recurrent, mainly sinopulmonary infections associated with increased serum IgE. The phenotype is variable, even within families. Some patients have onset of symptoms in early childhood and develop complications, including bronchiectasis or hemoptysis, whereas others have later onset of less severe infections. Immunologic workup usually shows normal leukocyte levels, although some patients may demonstrate alterations in lymphocyte subsets, including T cells. Affected individuals also have variable skeletal abnormalities, including high-arched palate, hyperextensible joints, scoliosis, and bone fractures. The IL6ST mutations are loss-of-function, although the truncated mutant proteins are expressed and interfere with the wildtype protein in a dominant-negative manner by disrupting IL6 (147620) and IL11 (147681) signaling (summary by Beziat et al., 2020). For a discussion of genetic heterogeneity of hyper-IgE syndrome, see HIES1 (147060).
Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection
MedGen UID:
1823965
Concept ID:
C5774192
Disease or Syndrome
Immunodeficiency-107 with susceptibility to invasive Staphylococcus aureus infection (IMD107) is an autosomal dominant immunologic disorder characterized most often by the development of invasive and severe life-threatening infections with S. aureus affecting the skin and/or lungs. There is incomplete penetrance (about 30%) and variable expressivity. In some patients with heterozygous OTULIN mutations, an infectious agent is not identified, suggesting that low-grade infectious or even noninfectious triggers may play a role in development of the disease. The levels and function of immune cells appear normal; the molecular defect resides in fibroblasts and possibly other nonhematopoietic barrier cells that show increased susceptibility to the detrimental effects of the S. aureus alpha-toxin (Spaan et al., 2022).

Professional guidelines

PubMed

Fu K, White K, Ramaniuk A, Kollu V, Urbine D
Emerg Infect Dis 2023 Jun;29(6):1266-1267. doi: 10.3201/eid2906.221854. PMID: 37209690Free PMC Article
Lewer D, Hope VD, Harris M, Kelleher M, Jewell A, Pritchard M, Strang J, Morley KI
Drug Alcohol Depend 2020 Jul 1;212:108057. Epub 2020 May 6 doi: 10.1016/j.drugalcdep.2020.108057. PMID: 32422537Free PMC Article
López J, Gómez G, Rodriguez K, Dávila J, Núñez J, Anaya L
Surg Infect (Larchmt) 2018 Apr;19(3):345-351. Epub 2018 Mar 13 doi: 10.1089/sur.2017.225. PMID: 29596040

Recent clinical studies

Etiology

Smiley C, Strunk A, Butt M, Kirby J, Garg A
Dermatology 2023;239(2):273-276. Epub 2022 Dec 20 doi: 10.1159/000528752. PMID: 36538899
Hu H, Mei J, Lin M, Wu X, Lin H, Chen G
Front Endocrinol (Lausanne) 2022;13:996863. Epub 2022 Dec 7 doi: 10.3389/fendo.2022.996863. PMID: 36568121Free PMC Article
Chambers HF
Infect Dis Clin North Am 2021 Mar;35(1):169-181. Epub 2020 Dec 7 doi: 10.1016/j.idc.2020.10.006. PMID: 33303334
Mohamedahmed AYY, Zaman S, Stonelake S, Ahmad AN, Datta U, Hajibandeh S, Hajibandeh S
Langenbecks Arch Surg 2021 Jun;406(4):981-991. Epub 2020 Aug 1 doi: 10.1007/s00423-020-01941-9. PMID: 32740696
Badour J, Singh M, Jones J
Emerg Med J 2018 Feb;35(2):126-127. doi: 10.1136/emermed-2017-207424.2. PMID: 29351926

Diagnosis

Smiley C, Strunk A, Butt M, Kirby J, Garg A
Dermatology 2023;239(2):273-276. Epub 2022 Dec 20 doi: 10.1159/000528752. PMID: 36538899
Kody S, Cline A, Pereira FA
J Dermatolog Treat 2022 May;33(3):1746-1748. Epub 2020 Dec 2 doi: 10.1080/09546634.2020.1853025. PMID: 33267625
Schmitz GR, Gottlieb M
Ann Emerg Med 2021 Jul;78(1):44-48. Epub 2021 Mar 24 doi: 10.1016/j.annemergmed.2020.12.003. PMID: 33771411
Garg A, Reddy S, Kirby J, Strunk A
Dermatology 2021;237(5):719-726. Epub 2020 Oct 23 doi: 10.1159/000511077. PMID: 33099547
Mistry RD
Pediatr Clin North Am 2013 Oct;60(5):1063-82. Epub 2013 Jul 30 doi: 10.1016/j.pcl.2013.06.011. PMID: 24093896

Therapy

Hu H, Mei J, Lin M, Wu X, Lin H, Chen G
Front Endocrinol (Lausanne) 2022;13:996863. Epub 2022 Dec 7 doi: 10.3389/fendo.2022.996863. PMID: 36568121Free PMC Article
Schmitz GR, Gottlieb M
Ann Emerg Med 2021 Jul;78(1):44-48. Epub 2021 Mar 24 doi: 10.1016/j.annemergmed.2020.12.003. PMID: 33771411
Chambers HF
Infect Dis Clin North Am 2021 Mar;35(1):169-181. Epub 2020 Dec 7 doi: 10.1016/j.idc.2020.10.006. PMID: 33303334
Mohamedahmed AYY, Zaman S, Stonelake S, Ahmad AN, Datta U, Hajibandeh S, Hajibandeh S
Langenbecks Arch Surg 2021 Jun;406(4):981-991. Epub 2020 Aug 1 doi: 10.1007/s00423-020-01941-9. PMID: 32740696
Mistry RD
Pediatr Clin North Am 2013 Oct;60(5):1063-82. Epub 2013 Jul 30 doi: 10.1016/j.pcl.2013.06.011. PMID: 24093896

Prognosis

Smiley C, Strunk A, Butt M, Kirby J, Garg A
Dermatology 2023;239(2):273-276. Epub 2022 Dec 20 doi: 10.1159/000528752. PMID: 36538899
Garg A, Reddy S, Kirby J, Strunk A
Dermatology 2021;237(5):719-726. Epub 2020 Oct 23 doi: 10.1159/000511077. PMID: 33099547
Ramirez-Schrempp D, Dorfman DH, Baker WE, Liteplo AS
Pediatr Emerg Care 2009 Jan;25(1):44-8. doi: 10.1097/PEC.0b013e318191d963. PMID: 19148015
Mootsikapun P, Intarapoka B, Liawnoraset W
Int J Infect Dis 2005 May;9(3):154-8. doi: 10.1016/j.ijid.2004.06.011. PMID: 15840456
Wanachiwanawin W
J Pediatr Hematol Oncol 2000 Nov-Dec;22(6):581-7. doi: 10.1097/00043426-200011000-00027. PMID: 11132234

Clinical prediction guides

Sachan S, Suvirya S, Yadav K, Gupta P, Saraswat A, Verma P, Chandra U, Singh BP, Chaudhary SC, Dwivedi DK, Garg RK, Singhai A, Malhotra KP, Parihar A, Kumar S
Indian J Dermatol Venereol Leprol 2023 Jul-Aug;89(4):510-523. doi: 10.25259/IJDVL_277_2022. PMID: 36688884
Smiley C, Strunk A, Butt M, Kirby J, Garg A
Dermatology 2023;239(2):273-276. Epub 2022 Dec 20 doi: 10.1159/000528752. PMID: 36538899
Hu H, Mei J, Lin M, Wu X, Lin H, Chen G
Front Endocrinol (Lausanne) 2022;13:996863. Epub 2022 Dec 7 doi: 10.3389/fendo.2022.996863. PMID: 36568121Free PMC Article
Garg A, Reddy S, Kirby J, Strunk A
Dermatology 2021;237(5):719-726. Epub 2020 Oct 23 doi: 10.1159/000511077. PMID: 33099547
Ramirez-Schrempp D, Dorfman DH, Baker WE, Liteplo AS
Pediatr Emerg Care 2009 Jan;25(1):44-8. doi: 10.1097/PEC.0b013e318191d963. PMID: 19148015

Recent systematic reviews

King A, Fegan K, Morgan K, Hill JE, Harrison J
Br J Community Nurs 2024 Mar 1;29(Sup3):S26-S30. doi: 10.12968/bjcn.2024.29.Sup3.S26. PMID: 38478417
Mohamedahmed AYY, Zaman S, Stonelake S, Ahmad AN, Datta U, Hajibandeh S, Hajibandeh S
Langenbecks Arch Surg 2021 Jun;406(4):981-991. Epub 2020 Aug 1 doi: 10.1007/s00423-020-01941-9. PMID: 32740696

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...